J 2020

Novel destabilizing Dynactin variant (DCTN1 p.Tyr78His) in patient with Perry syndrome

ČIERNY, Marek, Sam I HOOSHMAND, Dominic FEE, Swarnendu TRIPATHI, Nikita R DSOUZA et. al.

Basic information

Original name

Novel destabilizing Dynactin variant (DCTN1 p.Tyr78His) in patient with Perry syndrome

Authors

ČIERNY, Marek, Sam I HOOSHMAND, Dominic FEE, Swarnendu TRIPATHI, Nikita R DSOUZA, Alison La Pean KIRSCHNER, Michael T ZIMMERMANN and Ryan BRENNAN

Edition

PARKINSONISM & RELATED DISORDERS, OXFORD, ELSEVIER SCI LTD, 2020, 1353-8020

Other information

Type of outcome

Článek v odborném periodiku

Confidentiality degree

není předmětem státního či obchodního tajemství

References:

Impact factor

Impact factor: 4.891

UT WoS

000578015000025

Keywords in English

Atypical parkinsonism; DCTN1; Dynactin; Genetics; Perry disease; Perry syndrome; Microtubules; Type 2 respiratory failure; Autophagy; Nocturnal hypopnea; p150(Glued); Protein stability; Predicted folding free energy; Protein modeling; Microtubule associated protein RP/EB family member 1; EB1
Změněno: 18/9/2023 21:08, MUDr. Marek Čierny

Abstract

V originále

Introduction: Perry syndrome, also recognized as Perry disease, is a rare autosomal dominant disorder characterized by midlife-onset atypical parkinsonism, apathy or depression, respiratory failure and weight loss caused by a mutation in the Dynactin (DCTN1) gene.